Listen to this articleBelow is our recent interview with Richard Graves, Co-founder and Chief Commercial Officer at Sorcero:
Q: Richard, can tell us something more about your platform and company?
A: Sorcero is the leader in medical and technical Language Intelligence (LI), for Life Sciences and STEM enterprises. Our platform delivers a 1,000% increase in analytical capability and extracts advanced analytics and complex insights to augment critical decision-making for some of the world’s largest and most innovative pharmaceutical, diagnostic, and biotech organizations from scientific content. This supports the transformation of scientific engagement with real-time content intelligence, clinical compliance, and guide medical affairs and commercialization via global medical insights.
Q: Any highlights on your recent announcement?
A: Sorcero is thrilled to be partnered with MEDiSTAVA, whose depth of scientific and therapy area expertise and deep roster of leading Life Science clients enables our augmented intelligence to be guided by best-in-class medical strategy. Sorcero’s domain-specific Language Intelligence solutions can be guided and tuned by medical analytics teams, like those at MEDiSTRAVA. Together, we deliver results that prove that Human+AI performance far exceeds the results from just human manual analysis or AI analysis alone, delivering medical insights to create a real competitive advantage and to improve medical decision-making.
Recommended: Voices Connects The Biggest And Most Beloved Brands With Professional Freelance Talent
Q: Can you give us more insights into your offering?
A: Sorcero’s Language Intelligence solutions are transforming scientific engagement from time-bound, one-off reports and projects into continuous monitoring and advanced analytics solutions, enabling medical affairs to transition from trying to “keep up” on a vast volume of content to turning that content into a powerful asset that makes them highly-sought after experts from healthcare providers and key opinion leaders, as healthcare providers all over the world are transitioning to a new pace of change.
Q: What can we expect from your company in next 6 months? What are your plans?
A: Sorcero’s LI platform today is delivering next-generation analytics at scale, providing AI capabilities on over 39 million abstracts and 7.2 million full-text articles. Over the next six months, our Global Medical Insights platform is delivering augmented analytics on internal insights databases at leading Life Sciences companies and transforming scientific content in medical engagement assets in real-time, supporting some of the core pain points in Life Sciences and Healthcare, as the volume and complexity of medical content is growing faster than in any other sector at 36% CAGR.
Recommended: An Interview With Sebastien Breteau, The Founder And CEO Of QIMA
Q: What is the best thing about your company that people might not know about?
A: Sorcero’s technology was based on ideas coming from science fiction, including the Hitchhiker’s Guide to the Galaxy and the Diamond Age, where our other founders, Dipanwita Das connected over how AI could augment and support people in making better decisions in very complex environments, not just automate processes. Walter Bender, our CTO, built the first iteration of that technology after having led the MIT Media Lab and today we are delivering it to support some of the most important decisions in the world.
Activate Social Media:
